FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer

2.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

3.

New Immune Therapy Boosts Disease Control in Prostate Cancer

4.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

5.

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot